Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In this study, we show that there are differences in effects between wild-type (wt-) and differentiated ARPE19 cells (diff-ARPE19), implying that the cellular differentiation status may influence how cells respond to MOTS-c
Researchers do not yet have completed large-scale evidence establishing therapeutic effectiveness, standardized dosing, long-term safety, or broad clinical usefulness
Blood glucose and insulin levels of rats were measured after 7-weeks of feeding with the high-fat and high-sugar diet, and the insulin resistance index was calculated
AOD-9604 and MOTS-c are currently not approved by the FDA as drugs for treating specific medical conditions, though they are commonly used for improving metabolic efficiency
